The goal discussed in clinical settings is to support the bodys fat-metabolism support, which decline naturally with age
License Suspension: DMV could suspend the license for 6 months to 1 year
This compound is produced under stringent GMP-compliant conditions and provided as a stable lyophilized powder to support purity, stability, and reproducibility in experimental applications
There is no approved medical use , no licensed therapeutic indication, and no basis for human recommendations
A comparative study of the BPC 157 beneficial effect was done with intraperitoneal application, once daily, intraperitoneally (per kg body weight) 10 g, 10 ng, or 10 pg BPC 157, while standard agents 10 mg atropine, 50 mg ranitidine, and 50 mg omeprazole provide only a weak effect